NI

Narayana Iyer Krishna Iyer

Director Director DIN 01998531
DIN 01998531 First appointment Sep 2009 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Sep 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Narayana Iyer Krishna Iyer

Data last updated:

Narayana Iyer Krishna Iyer has 17 years in corporate governance. Formerly with 1 company, such as Chemwel Pharma Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01998531
Primary Designation Director
First Appointment 16 Sep 2009
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chemwel Pharma Limited U24231KL1998PLC012114
Director16 Sep 20091998₹59.6 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chemwel Pharma Limited
Premium access

Shareholding and investment profile for Narayana Iyer Krishna Iyer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narayana Iyer Krishna Iyer

Narayana Iyer Krishna Iyer has 17 years in corporate governance. Formerly with 1 company, such as Chemwel Pharma Limited. Engaged in General Business. Contributes to corporate operations.

Narayana Iyer Krishna Iyer has expertise in General Business.

Narayana Iyer Krishna Iyer has 17 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available